Related Experiment Video
Updated: Jul 5, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Post-Treatment Causes of Encephalopathy
Rami W Eldaya1, Matthew S Parsons2
1Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
This article provides a comprehensive review of acute encephalopathic syndromes caused by multiple therapeutic medications, emphasizing their imaging features and underlying mechanisms. It covers chemotherapeutic-related acute encephalopathies such as acute toxic leukoencephalopathy, posterior reversible encephalopathy syndrome, and neurovascular complications of chemotherapy; immunotherapy-induced neurotoxicities including immunotherapy-associated encephalitis, aseptic meningitis, cranial neuropathies, demyelination, and hypophysitis; and chimeric antigen receptor T-cell therapy-related syndromes such as cytokine release syndrome, immune effector cell-associated neurotoxicity, and tumor inflammation-associated neurotoxicity. Toxicities from non-cancer medications-metronidazole, vigabatrin, and anti-amyloid monoclonal antibodies-are also discussed.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Brain Abscess l: Introduction
Cerebral Edema ll: Pathophysiology
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
